Akash A Shah

Dr. Akash A Shah


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
JSJoseph H. Schwab
Joseph H. Schwab
ASAkash A Shah
Akash A Shah
An infection of the spinal epidural space, spinal epidural abscess (SEA) is a potentially devastating entity that is rising in incidence. Its insidious presentation, variable progression, and potential for precipitous neurologic decline make diagnosis and management of SEA challenging. Prompt diagnosis is key because treatment delay can lead to paralysis or death. Owing to the nonspecific symptoms and signs of SEA, misdiagnosis is alarmingly common. Risk factor assessment to determine the need for definitive MRI reduces diagnostic delays compared with relying on clinical or laboratory findings alone. Although decompression has long been considered the benchmark for SEA, considerable risk associated with spinal surgery is noted in an older cohort with multiple comorbidities. Nonoperative management may represent an alternative in select cases. Failure of nonoperative management is a feared outcome associated with motor deterioration and poor clinical outcomes. Recent studies have identified independent predictors of failure and residual neurologic dysfunction, recurrence, and mortality. Importantly, these studies provide tools that generate probabilities of these outcomes. Future directions of investigation should include external validation of existing algorithms through multi-institutional collaboration, prospective trials, and incorporation of powerful predictive statistics such as machine learning methods.

1 October 2019 in The Spine Journal
Verified
Journal Article
Closed access
ASAkash A Shah
Akash A Shah
AKAditya V. Karhade
Aditya V. Karhade
CBChristopher M. Bono
Christopher M. Bono
MHMitchel B. Harris
Mitchel B. Harris
SNSandra B. Nelson
Sandra B. Nelson
JSJoseph H. Schwab
Joseph H. Schwab

1 October 2021 in The Spine Journal
Verified
Journal Article
Closed access
ASAkash A Shah
Akash A Shah
AKAditya V. Karhade
Aditya V. Karhade
HPHoward Y. Park
Howard Y. Park
WSWilliam L. Sheppard
William L. Sheppard
LMLuke J. Macyszyn
Luke J. Macyszyn
FHFrancis J. Hornicek
Francis J. Hornicek

20 June 2018 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
ASAkash A Shah
Akash A Shah
POPaul T. Ogink
Paul T. Ogink
MHMitchel B. Harris
Mitchel B. Harris
JSJoseph H. Schwab
Joseph H. Schwab
Background: Spinal epidural abscess is a high-risk condition that can lead to paralysis or death. It would be of clinical and prognostic utility to identify which subset of patients with spinal epidural abscess is likely to develop a motor deficit or die within 90 days of discharge. Methods: We identified all patients ≥18 years of age who were admitted to our hospital system with a diagnosis of spinal epidural abscess during the period of 1993 to 2016. Explanatory variables were collected retrospectively. Bivariate and multivariable logistic regression was performed using these variables to identify independent predictors of motor deficit and 90-day mortality. Nomograms were then constructed to quantify the risk of these outcomes. Results: Of the 1,053 patients we identified with spinal epidural abscess, 362 presented with motor weakness. One hundred and thirty-four patients died within 90 days of discharge, inclusive of those who died during hospitalization. Multivariable logistic regression yielded 8 independent predictors of pre-treatment motor deficit and 8 independent predictors of 90-day mortality. We constructed nomograms that generated a probability of pre-treatment motor deficit or 90-day mortality on the basis of the presence of these factors. Conclusions: By quantifying the risk of pre-treatment motor deficit and 90-day mortality, our nomograms may provide useful prognostic information for the treatment team. Timely treatment of neurologically intact patients with a high risk of developing a motor deficit is necessary to avoid residual motor weakness and improve survival. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of Levels of Evidence.

1 August 2021 in World Neurosurgery
Verified
Journal Article
Closed access
ASAkash A Shah
Akash A Shah
SDSai K. Devana
Sai K. Devana
CLChanghee Lee
Changhee Lee
ABAmador Bugarin
Amador Bugarin
ELElizabeth L. Lord
Elizabeth L. Lord
NSNelson F. SooHoo
Nelson F. SooHoo

14 July 2022 in The Spine Journal
Verified
Journal Article
Closed access
AKAditya V. Karhade
Aditya V. Karhade
BFBrian Fenn
Brian Fenn
OGOlivier Q. Groot
Olivier Q. Groot
ASAkash A Shah
Akash A Shah
HYHung-Kuan Yen
Hung-Kuan Yen
JSJoseph H. Schwab
Joseph H. Schwab